Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.590

+3.6%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: PLegee	1/14/2011 11:54:51 PM
	Read Replies (1) of 368

1 million shares traded today, huge volume in the last hour; volume has been building since late November. Catalysts include an upcoming release of HIV clinical results that are indicated to be outstanding as referenced in health care symposiums and numerous medical journals (program update from company not yet released; 1st qtr 2011), and their SB-509-901 trials, an activator of the gene encoding vascular endothelial growth factor-A (VEGF-A) for diabetic nephropathy (DN). ALS studies are also underway but preliminary results will not be available for quite some time (1st qtr 2012 I recall). Near term resistance is ~$8.50; new 52 week high today. Volume increase is a definite sign of institutional activity. If HIV data is as good as has been suggested, this current breakout will appear to be minor in comparison. Should be interesting times ahead. If HIV or SB-509 updates disappoint, the stock most certainly will be sub $4 once again. Ideally, the stock needs to base at these levels to consolidate recent gains before attempting to take out the resistance above. A possible headwind for continued price appreciation is consideration of a secondary offering needed to insure adequate cash flow for next years operations. The current burn rate is $25M with a current cash balance of $60M. At these higher stock price levels, a secondary offering would seem to be an enticing and efficient way to raise funds by management.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next